OptiBiotix Health Plc (AIM:OPTI)
London · Delayed Price · Currency is GBP · Price in GBX 5.64
-0.01 (-0.18%)
Oct 15, 2026, 2:00 PM GMT
OptiBiotix Health Market Cap
OptiBiotix Health has a market cap or net worth of 5.83 million as of October 15, 2026. It is the 42,990th most valuable company in the world and the 968th biggest in the United Kingdom. Its market cap has decreased by 39.03% in one year.
Market Cap
5.83M
Enterprise Value
4.84M
Revenue
1.29M
Global Rank
Country Rank
#968 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since August 5, 2014, OptiBiotix Health's market cap has decreased from 6.46M to 5.83M, a decrease of -9.78%. That is a compound annual growth rate of -0.84%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 5.83M | -16.44% |
| Dec 31, 2025 | 6.97M | -60.45% |
| Dec 31, 2024 | 17.63M | -27.73% |
| Dec 29, 2023 | 24.39M | 101.89% |
| Dec 30, 2022 | 12.08M | -70.13% |
| Dec 31, 2021 | 40.45M | -20.69% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Palatin Technologies | 12.25M |
| Fusion Antibodies | 12.20M |
| Aptamer Group | 11.23M |
| Thalia Therapeutics | 11.10M |
| Genflow Biosciences | 10.00M |
| Solvonis Therapeutics | 7.66M |
| CRISM Therapeutics | 7.13M |
| Cizzle Biotechnology Holdings | 5.95M |